key: cord-0959081-nhg09ye6 authors: Kolodziej, L M; van Lelyveld, S F L; Haverkort, M E; Mariman, R; Sluiter-Post, J G C; Badoux, P; de Koff, E M; Koole, J C D; Miellet, W R; Swart, A N; Coipan, E C; Meijer, A; Sanders, E A M; Trzciński, K; Euser, S M; Eggink, D; van Houten, M A title: High SARS-CoV-2 household transmission rates detected by dense saliva sampling date: 2022-04-06 journal: Clin Infect Dis DOI: 10.1093/cid/ciac261 sha: 2a2dfd9f7aeebbe3c7a18be0696ce17bce8dbc74 doc_id: 959081 cord_uid: nhg09ye6 BACKGROUND: Understanding the dynamics of SARS-CoV-2 household transmission is important for adequate infection control measures in this ongoing pandemic. METHODS: Households were enrolled upon a PCR-confirmed index case between October and December 2020, prior to the COVID-19 vaccination program. Saliva samples were obtained by self-sampling at day 1, 3, 5, 7, 10, 14, 21, 28, 35, and 42 from study inclusion. Nasopharyngeal swabs (NPS) and oropharyngeal swabs (OPS) were collected by the research team at day 7 and capillary blood samples at day 42. Household secondary attack rate (SAR) and per-person SAR were calculated based on at least one positive saliva, NPS, OPS, or serum sample. Whole genome sequencing was performed to investigate the possibility of multiple independent SARS-CoV-2 introductions within a household. RESULTS: Eighty-five households were included consisting of 326 (unvaccinated) individuals. Comparable numbers of secondary cases were identified by saliva (133/241; 55.2%) and serum (127/213; 59.6%). The household SAR was 88.2%. The per-person SAR was 64.3%. The majority of the secondary cases tested positive in saliva at day 1 (103/150; 68.7%). Transmission from index case to household member was not affected by age or the nature of their relationship. Phylogenetic analyses suggested a single introduction for the investigated households. CONCLUSION: Households have a pivotal role in SARS-CoV-2 transmission. By repeated saliva self-sampling combined with NPS, OPS, and serology, we found the highest SARS-CoV-2 household transmission rates reported to date. Salivary (self-)sampling of adults and children is suitable and attractive for near real-time monitoring of SARS-CoV-2 transmission in this setting. Since the first identification in December 2019, coronavirus disease 2019 (COVID-19) numbers continue to increase and have passed 245 million cases globally. [1] Insight into transmission dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of major importance for infection control measures. While the current standard testing method for SARS-CoV-2 detection is mainly via reverse transcription polymerase chain reaction (RT-PCR) on nasopharyngeal swabs (NPS), [2] other specimens like saliva may also offer a good source for detection by RT-PCR. [3, 4] Multiple studies have demonstrated a comparable or higher sensitivity of detecting SARS-CoV-2 using saliva compared to NPS, both in adults and children. [5] [6] [7] [8] [9] Furthermore, RT-PCR on saliva effectively identifies SARS-CoV-2 even before the period of infectiousness [10] and particularly high sensitivity rates of RT-PCR on saliva have been found among studies involving asymptomatic individuals. [11, 12] Compared to NPS, salivary testing is less invasive and samples can be easily collected by individuals themselves (including children with assistance of their parents) without need of qualified personnel, allowing frequent sampling. Moreover, salivary self-sampling has been shown to be more sensitive than self-administered nasal swabs. [5] Salivary self-sampling could therefore contribute to improved monitoring and lower costs. [13] As not only symptomatic, but also asymptomatic and pre-symptomatic individuals are considered to be potential sources of new infections, [14, 15] high-density salivary sampling (i.e. frequent sampling in a short time period) for RT-PCR testing of SARS-CoV-2 can be applied to investigate SARS-CoV-2 transmission in households. Households are considered to be one of the most frequent settings of SARS-CoV-2 transmission with close contact between members over long time within confined spaces without use of personal protective equipment (PPE). [16] The reported secondary attack rates (SARs) of previous household studies show a wide range of transmission from 6% to 50%, depending on the study setting, study period, frequency of testing, testing method, and specimen types analysed. [17] [18] [19] [20] [21] [22] [23] [24] Since the majority of these studies have been Upcoming variants associated with higher transmissibility [25] contribute to the persistence of the SARS-CoV-2 pandemic. A better understanding of SARS-CoV-2 transmission dynamics, including the role of children, will support the rationale behind public health policies, like school closure and other infection control measures. The aim of this study is to assess household transmission dynamics of SARS-CoV-2 by frequent saliva sampling in combination with NPS, OPS and serology, to determine factors associated with transmission, and to investigate the suitability of salivary (self-) sampling to monitor SARS-CoV-2 household transmission. In this prospective cohort study "SARSLIVA" (SARS-CoV-2 in saLIVA), households were eligible in case of an index case under the age of 65 years SARS-CoV-2 infection with RT-PCR confirmed SARS-CoV-2 on a combined NPS and oropharyngeal swab (OPS) during the previous 72 hours (index case) and with at least two additional household members willing to participate in the study. Between October and December 2020, prior to the COVID-19 vaccination program, participants were recruited by the An online baseline questionnaire was obtained at day 0. This questionnaire contained questions on household composition, household characteristics, smoking, medical history, self-reported ethnicity, and educational level. Each night before the pre-defined time points for saliva collection, online COVID-19 symptomatology questionnaires were sent to the participants, consisting of self-perceived severity scores ("no", "mild", "moderate", "severe") per symptom. Medical records were obtained if participants were admitted to a hospital or visited a general practitioner during the study period. The first member of each household with a RT-PCR confirmed SARS-CoV-2 infection included in the study was defined as the index case. As this index case was not necessarily the primary case (the first SARS-CoV-2 infection) in a household, we performed a sensitivity analysis with a more stringent index case definition (see Statistical methods). SARS-CoV-2 infection during follow-up was defined as either at least one positive SARS-CoV-2 RT-PCR result on one of the saliva samples, on NPS or OPS at day 7, or detection of serum antibodies at day 42, regardless of the presence of symptoms. COVID-19 disease severity was classified with a four-degree scale per time point, derived from national and international guidelines [26, 27] : (1) Initial combined NPS/OPS of the index cases as well as NPS and OPS obtained at day 7 were analysed for the presence of SRAS-CoV-2 by the Regional Public Health Laboratory Kennemerland, Haarlem, The Netherlands as described previously. SARS-CoV-2 viral loads in saliva samples were analysed by the laboratory of the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands as described before. [28, 29] See Supplementary Materials for details. Amplicon-based SARS-CoV-2 sequencing for was performed on the positive saliva sample with the highest viral load for each individual using the Nanopore protocol "PCR tiling of COVID-19 virus (Version: PTC_9096_v109_revE_06FEB2020)" which is based on the ARTIC v3 amplicon sequencing protocol. [30, 31] See Supplementary Materials for details. Sera were tested for the presence of IgG antibodies reactive with the SARS-CoV-2 spike trimer, S1, and N antigens in a protein microarray, in duplicate 2-fold serial dilutions starting at 1:20, essentially as described previously. [32] For each antigen, a 4-parameter log logistic calibration curve was generated and EC50 antibody titres were calculated. Raw data were processed with the R 4.04 statistical software. [33] Statistical methods The household SAR was calculated by dividing households with secondary transmission by the total number of households. Per-person SAR was calculated by dividing the number of secondary cases by the number of participating household members. Logistic regression models were used to compare characteristics of index cases and household members and to assess the relation between household SAR and per-person SAR and the characteristics of households, index cases, and household members. Statistical analyses were performed with R version 3.6.2 (R Core Team, Vienna, Austria). P-values <0.05 were considered significant. In total 390 index cases were approached of whom 91 were included. Six dropped out resulting in a total of 85 households consisting of 326 (unvaccinated) participants (85 index cases and 241 household members). For all participants (n=326), protocol adherence for collection of the specimens was 92.4% (94.8% saliva, 92.9% NPS, 93.6% OPS, and 88.4% serum). A c c e p t e d M a n u s c r i p t 8 The median size of the households was four (IQR 3.0-4.0) participating household members (Table 2) . Of the household members, 64.3% tested positive in at least one saliva, NPS, OPS, or serum specimen (155/241 secondary cases; Figure 1 ). Household members tested positive for SARS-CoV-2 in saliva in 55.2% (133/241) and for SARS-CoV-2 antibodies in serum at day 42 in 59.6% (127/213). (Table 4 ). The sensitivity analysis excluding 27 households (27 index cases and their 75 household members) with a possible other primary case than our defined index case resulted in a household SAR of 82.8% (48/58 households) and a per-person SAR of 54.2% (90/166 household members). Characteristics of index cases, households, or household members associated with secondary transmission were not remarkably different between the primary and sensitivity analysis (Supplementary Tables 1-3) . A c c e p t e d M a n u s c r i p t 10 In this study we have investigated household transmission dynamics of SARS-CoV-2 by frequent and dense saliva sampling in combination with serology, NPS, and OPS in 85 households with a RT-PCR confirmed index case. We found a household SAR of 88.2%, the highest rate of SARS-CoV-2 household transmission reported up to date. The majority of the secondary cases were identified by saliva only. As approximately two thirds of the secondary cases were already detected at the first sampling event, our study underlines that household transmission occurs rapidly. Secondary transmission was detected from and to different age groups and relationships within households, indicating that children, as well as adults, are at risk of infection and spreading of SARS-CoV-2 among their household members. Additional phylogenetic analyses suggest a single introduction for the investigated households. A possible explanation for the high SARs in our study could be that other studies performed repeat sampling only in case of symptomatology, thereby ignoring possible asymptomatic cases within the household. [18, 20, 24, 34, 35] In addition, the high frequency and density of salivary sampling may have contributed to the higher SARs in our study compared to earlier reports. [19, 22, 35] We found the highest sensitivity of SARS-CoV-2 detection by salivary testing combined with serological analyses. However, the performance of salivary testing alone was comparable and its timely results could serve infection control purposes while serological analyses could not. Two other prospective household studies used saliva as specimen to detect SARS-CoV-2 transmission. [19, 23] One of these studies [23] reported a lower per-person SAR of 43%, possibly because salivary sampling was performed less frequently than in our study and additional sampling was performed only in case of symptoms. In our study, we found that 58 out of the 155 secondary cases were asymptomatic and the per-person SAR would have declined from almost 65% to 40% if only symptomatic individuals would have been included. Saliva identified over 75% (44/58) of the asymptomatic secondary infections. This confirms saliva (self-)sampling being highly effective in detecting asymptomatic SARS-CoV-2 infections in adults and older children. [11, 12] In addition, the non-invasive character of M a n u s c r i p t 11 salivary (self-)sampling facilitates frequent use for near-real time monitoring in symptomatic as well as asymptomatic individuals. Salivary (self-) sampling of household members in the first week after symptom onset or positive test of a household index case could therefore improve infection control in this setting. Although in the context of high transmission rates, household isolation may be more practical and cost-effective. Other factors that may have affected SARs are the study period including vaccination status of the participants (the COVID-19 vaccination program had not started yet), quarantine policies, and dominating variants (Nextclade 20A, 20B, 20E (EU1)) associated with different transmission rates. [36] All participants were recruited in the second wave of COVID-19 infections in the Netherlands (approximately from July 2020 to January 2021), in which working at home was encouraged or enforced and school classes generally took place at home, hereby possibly increasing the risk of household transmission. [16] In this study, we aimed to identify factors associated with secondary transmission. We found no apparent association between index case, household, or household member characteristics and secondary transmission. These findings are not fully in line with previous studies. In our study, transmission from index case to household member was not affected by age or the nature of their relationship. In contrast, several studies indicate that children (<18 years) play a minor role in household transmission of SARS-CoV-2, but caution must be applied here as the number of index children in these studies was low. [17, 19, 21, 24] In these studies, as well as in our study, the number of younger index children (<12 years) was too small to draw reliable conclusions regarding their role in transmission. We can however conclude that introduction and spreading of SARS-CoV-2 in households appears difficult to prevent as it occurs fast and involves household members of different age groups. A limitation of our study is that index cases were defined as the first included household member. However, not all index cases might have been the primary cases within the household and coprimary cases were not considered which could have caused an overestimation of the per-person A c c e p t e d M a n u s c r i p t 30 Figure 3 COVID-19 dashboard by the center for systems science and engineering (CSSE) . Available at Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing Saliva is a reliable tool to detect SARS-CoV-2 Detection of SARS-CoV-2 in different types of clinical specimens Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2 Performance of RT-PCR on saliva specimens compared with nasopharyngeal swabs for the detection of SARS-CoV-2 in children: A prospective comparative clinical trial The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs : A systematic review and meta-analysis Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: A systematic review and metaanalysis Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection Comparing nasopharyngeal swab and early morning saliva for the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Saliva is a reliable and accessible source for the detection of SARS-CoV-2 Willingness to seek diagnostic testing for SARS-CoV-2 with home, drive-through, and clinic-based specimen collection locations Characterization of an asymptomatic cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals outside of wuhan, china Transmission of 2019-nCoV infection from an asymptomatic contact in germany Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 Household transmission of SARS-CoV-2, zhuhai, china Contact tracing assessment of COVID-19 transmission dynamics in taiwan and risk at different exposure periods before and after symptom onset Transmission of SARS-COV-2 infections in householdstennessee and wisconsin Attack rates amongst household members of outpatients with confirmed COVID-19 in bergen, norway: A case-ascertained study Household transmission of SARS-CoV-2 in the united states: Living density, viral load, and disproportionate impact on communities of color Characteristics of household transmission of COVID-19 High infection secondary attack rates of SARS-CoV-2 in dutch households revealed by dense sampling Transmission of SARS-CoV-2 within households: A prospective cohort study in the netherlands and belgium -interim results Comparative household secondary attack rates associated with B.1.1.7, B.1.351, and P.1 SARS-CoV-2 variants COVID-19 treatment guidelines -clinical spectrum of SARS-CoV-2 Detection of 2019 novel coronavirus (2019-nCoV) by realtime RT-PCR Diagnosis of human metapneumovirus and rhinovirus in patients with respiratory tract infections by an internally controlled multiplex real-time RNA PCR PCR tiling of COVID-19 virus Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach Profiling of humoral immune responses to influenza viruses by using protein microarray Transmission dynamics of COVID-19 in household and community settings in the united kingdom Household transmission of severe acute respiratory syndrome coronavirus-2 in the united states Factors associated with household transmission of SARS-CoV-2: An updated systematic review and meta-analysis Z-score data files A c c e p t e d M a n u s c r i p t 17